Skip to main content

Table 1 Patients’ characteristics at baseline (n = 40, 100%)

From: To coagulate, ligate, or both: a randomized study comparing the safety and efficacy of two endoscopic approaches for managing gastric antral vascular ectasia in cirrhotic patients

Comparative factors Group I: combined therapy group Group II: EBL group P value
Mean/Count %/±SD Mean/count %/±SD
History and clinical finding
 History of hepatic encephalopathy 4 20% 5 25% 0.705
 History of bilharziasis 5 25% 4 20% 0.705
 Previous treatment of oesophageal varices 9 45% 8 40% 0.749
 Bleeding tendency (epistaxis, bleeding gums, ecchymotic patches at venipuncture sites) 9 45% 8 40% 0.749
 Pallor 20 100% 18 90% 0.136
 Palmar erythema 7 35% 8 405 0.744
 Lower limb edema 5 25% 8 40% 0.311
 Jaundice 7 35% 5 25% 0.490
 Spider nevi 5 25% 11 55% 0.053
 Dilated abdominal veins 3 15% 3 15% 1
 Fever 2 10% 3 15% 0.633
Demographic features
 Age (years) 57.75 ± 7.51 57.35 ± 8.28 0.874
 Sex (female/male) 9/11 45%/55% 7/13 35%/65% 0.519
 Residence (urban/rural) 7/13 35%/65% 5/15 25%/75% 0.490
Etiology of liver cirrhosis
 HCV 18 90 20 100% 0.349
 HBV 1 5% 0 0%
 Non-viral 1 5% 0 0%
Child-Turcotte-Pugh classification
 Class A 8 40% 8 40% 0.920
 Class B 6 30% 5 25%
 Class C 6 30% 7 35%
Laboratory findings
 ALT (U/L) 45.60 ± 16.46 48.10 ± 21.72 0.978
 AST (U/L) 56.65 ± 22.80 50.85 ± 20.22 0.464
 Albumin (g/dL) 2.68 ± 0.59 2.73 ± 0.63 0.587
 Total bilirubin (mg/dl) 2.28 ± 1.24 2.47 ± 1.69 0.924
 Prothrombin concentration 58.80 ± 12.79 60.80 ± 17.36 0.498
 White blood cell (× 103/mm3) 5.46 ± 2.6 5.48 ± 2.6 0.968
 Platelet count (103/mm3) 84.80 ± 29.844 91.80 ± 61.10 0.756
 Hemoglobin (g/dL) 6.86 ± 1.25 7.71 ± 1.66 0.074
  1. Unless otherwise stated numerical data are expressed as mean (SD)
  2. Abbreviations: ALT alanine aminotransferase, AST aspartate aminotransferase, EBL endoscopic band ligation, HBV hepatitis B virus; HCV hepatitis C virus
  3. P > 0.05 = not significant